Data Breach Law Group Investigates the Fresenius Kabi USA, LLC Data Breach
By Data Breach Law Group | Posted on June 17, 2026 · Vermont
Miami, FL — Data Breach Law Group is investigating a data breach involving Fresenius Kabi USA, LLC, reported to the Vermont Attorney General on June 17, 2026. The firm is reviewing whether affected individuals have legal claims arising from the incident.
Fresenius Kabi USA, LLC is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition. As a major provider in the pharmaceutical and medical device sector, the company maintains sensitive records including patient medical histories, health insurance details, and personal identification information necessary for clinical operations. In 2026, the company officially reported a data security incident to the Vermont Attorney General, confirming that unauthorized access to their systems occurred. If you have received a data breach notification letter from Fresenius Kabi, it indicates that your personal or health-related information may have been compromised during this event. We recommend reviewing the letter carefully to understand the specific scope of the exposure and the identity monitoring services being offered.
If you were affected
Stay alert to targeted scams
Be cautious of calls, texts, or emails that reference this breach. Legitimate organizations won't ask you to confirm sensitive details through an unsolicited message.
Keep your notification letter
Save the notice you received. It documents that your information was involved and is often needed to enroll in any credit monitoring offered or to join a related legal claim.
Did you receive a letter from Fresenius Kabi USA, LLC?
A case review is free and confidential. Tell us about your letter and we will explain your options.